ImmuPharma (LON:IMM) Shares Up 7.5% – Here’s What Happened

ImmuPharma plc (LON:IMMGet Free Report) shot up 7.5% during trading on Monday . The stock traded as high as GBX 1.32 ($0.02) and last traded at GBX 1.32 ($0.02). 1,167,245 shares were traded during trading, a decline of 34% from the average session volume of 1,776,601 shares. The stock had previously closed at GBX 1.23 ($0.02).

ImmuPharma Price Performance

The company has a market cap of £5.50 million, a PE ratio of -122.80 and a beta of 1.53. The stock’s 50-day moving average is GBX 1.72 and its 200 day moving average is GBX 1.85.

About ImmuPharma

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

See Also

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.